First-in-human Safety Study of Hypoimmune Pancreatic Islet Transplantation in Adult Subjects With Type 1 Diabetes
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
Type1diabetes
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Uppsala University Hospital, Uppsala, Sweden
Study leads
Per-Ola Carlsson, MD, PhD
Principal Investigator
Uppsala University Hospital